Preventing Gastric Glitch With Prucalopride and Buspirone: N-of-1 Clinical Trial

The requested reference [1d5b89d42819f3c0096f4f2781ebb835d6eab224] no longer exists in our database. It has been replaced by the current reference: [f6f43902fb9fb70a1ebd04c205a6ed2ae91fe06a]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
Background: Gastric glitch is a new functional disease characterized by severe and transient epigastric pain occurring after challenges such as drinking alcohol and eating specific foods. Aims: In this N-of-1 trial, we first characterized the clinical and gastric tomographic images of a patient with gastric glitch highly reproducible after alcohol challenging, and then tested the effect of prucalopride and buspirone on the prevention of gastric glitch crises.
Epistemonikos ID: 1e59718676e955aa82fb84cf9368e31e2dc2a468
First added on: May 13, 2024